Earnings Per Share | 9 Months Ended |
Jan. 31, 2015 |
Earnings Per Share [Abstract] | |
Earnings Per Share | Note C - Earnings Per Share |
|
The following table sets forth the computation of basic and diluted earnings per share: |
|
|
|
| | | | | | | | | | | |
| Three Months Ended | | Nine Months Ended |
| January 31, | | January 31, |
| 2015 | | 2014 | | 2015 | | 2014 |
| | | | | | | | | | | |
Net income | $ | 564,080 | | $ | 743,794 | | $ | 727,319 | | $ | 2,495,912 |
Weighted-average shares | | | | | | | | | | | |
Basic | | 4,054,146 | | | 3,966,814 | | | 4,042,307 | | | 3,963,093 |
Effect of dilutive stock options | | 61,869 | | | 121,881 | | | 79,350 | | | 92,805 |
| | | | | | | | | | | |
Diluted | | 4,116,015 | | | 4,088,695 | | | 4,121,657 | | | 4,055,898 |
| | | | | | | | | | | |
Basic earnings per share | $ | 0.14 | | $ | 0.19 | | $ | 0.18 | | $ | 0.63 |
| | | | | | | | | | | |
Diluted earnings per share | $ | 0.14 | | $ | 0.18 | | $ | 0.18 | | $ | 0.62 |
|
|
Options to purchase 90,354 and 127,042 shares of common stock were outstanding at January 31, 2015 and 2014, respectively. There were no options granted during the quarter ended January 31, 2015 and 2014. The Company recognized $4,559 and $18,878 in stock option expense for the three month period ended January 31, 2015 and 2014, respectively. There were no options granted during the nine month period ended January 31, 2015 and 20,000 options were granted during the nine month period ended January 31, 2014. The Company recognized $27,491 and $52,976 in stock option expense for the nine months ended January 31, 2015 and 2014, respectively. The balance of unrecognized compensation expense related to the Company’s stock option plans was $26,118 and $76,743 at January 31, 2015 and 2014, respectively. |
|
The Company issued 25,000 shares of restricted stock on June 1, 2012, of which 8,330 vested in June 2012, 8,330 vested in June 2013 and 8,340 vested in June 2014. The Company recognized $0 and $3,362 in compensation expense for the three month period ended January 31, 2015 and 2014, respectively. The Company recognized $1,746 and $11,960 in compensation expense for the nine month period ended January 31, 2015 and 2014, respectively. There was no issuance of restricted stock to employees during the three and nine month periods ended January 31, 2015 and 2014, respectively. The balance of unrecognized compensation expense related to the Company’s restricted stock award was $0 and $5,107 and at January 31, 2015 and 2014, respectively. |
|
|
Note C - Earnings Per Share - Continued |
|
On October 1, 2013, the Company granted 1,500 shares to each non-employee director pursuant to the 2013 Non-Employee Director Restricted Stock Plan. A total of 7,500 restricted shares were granted and the shares vested six months from the date of grant. The Company recognized no compensation expense for the three and nine month periods ended January 31, 2015. The Company recognized $20,055 and $26,813 in compensation expense for the three and nine months ended January 31, 2014, respectively. At January 31, 2015, there was no unrecognized compensation expense related to the issuance of those 7,500 shares of restricted stock. |
|
On October 1, 2014, the Company granted 1,750 shares to each non-employee director pursuant to the 2013 Non-Employee Director Restricted Stock Plan. A total of 8,750 restricted shares were granted and the shares vest in six months from the date of grant. The Company recognized $30,431 and $40,685 in compensation expense for the three and nine months, respectively, for the period ended January 31, 2015. The balance of unrecognized compensation expense related to the 8,750 shares of restricted stock was $19,515 at January 31, 2015. |
|
The Company implemented an employee stock purchase plan (“ESPP”) for all eligible employees on February 1, 2014. The ESPP reserved 500,000 shares of common stock for issuance to employees. In addition, the number of shares of common stock reserved for issuance under the plan automatically increases on the first day of the Company’s fiscal years by 25,000 shares. For the three months ended January 31, 2015, 4,591 shares were issued under the ESPP and the Company recorded $6,469 in compensation expense. For the nine months ended January 31, 2015, 14,220 shares were issued under the ESPP and the Company recorded $26,344 in compensation expense. During the three and nine months ended January 31, 2015, the Company recorded $22,712 and $107,165, respectively, to stockholders’ equity relating to purchases under the ESPP. |
|
The Company offered to purchase 395,190 Eligible Options (as defined below) from Eligible Holders (as defined below) upon the terms stated in Schedule TO (“TO”) filed with the SEC on October 1, 2013. The stock options subject to the TO were those options to purchase SGMA common stock which had not expired or terminated prior to October 29, 2013, having the grant dates and exercise prices set forth in the TO (the “Eligible Options”). Eligible Options, all of which were fully vested, were granted under the following Company stock option plans: 1993 Stock Option Plan, 2004 Employee Stock Option Plan, 2000 Directors’ Stock Option Plan and 2004 Directors’ Stock Option Plan. |
|
“Eligible Holders” were: (a) those current or former employees, including all officers, who held Eligible Options as of October 29, 2013; and (b) all current or former directors of the Company, who held Eligible Options as of October 29, 2013. |
|
The Company offered to pay a cash amount ranging from $0.18 to $1.35 per Eligible Option, totaling up to $301,500, as specifically set forth in the TO. Each Eligible Holder who participated in the TO received cash payment (subject to tax and other withholding for employees) for each properly tendered Eligible Option promptly following October 29, 2013. |
|
The Company made this offer subject to the terms and conditions stated in the TO and 394,200 Eligible Options were tendered and purchased for a total cash payment of $300,410 as of October 31, 2013. |
|